<DOC>
	<DOCNO>NCT02561559</DOCNO>
	<brief_summary>In study investigator treat PM oligometastatic patient SBRT . Our objective evaluate rate local control treat lesion patient treated Intensity Modulated Radiation Therapy ( IMRT ) use Volumetric Modulated Arc Therapy ( VMAT ) lung metastasis STS .</brief_summary>
	<brief_title>SBRT Treatment Lung Metastasis From Soft Tissue Sarcoma</brief_title>
	<detailed_description>The investigator start treat PM oligometastatic patient Stereotactic Body Radiotherapy . The investigator objective evaluate rate local control treat lesion patient treated Intensity Modulated Radiation Therapy ( IMRT ) use Volumetric Modulated Arc Therapy ( VMAT ) lung metastases soft-tissue sarcoma . Overall disease free survival evaluate secondary endpoint .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Soft Tissue Neoplasms</mesh_term>
	<criteria>Age 18 anni 85 year PS accord ECOG 02 Histopathologically confirmation soft tissue sarcoma Metastatic lung lesion le 4 Controlled primary tumor metastatic lesion Metastatic lesion le 5 definition oligometastatic patient Written inform consent Contraindication surgical resection Estimated survival ≥ 3 month Absence progressive disease longer 6 month No chemotherapy give least 3 month SBRT Maximum diameter ≤ 5 cm Prior thorax radiation therapy Age &gt; 85 year PS accord ECOG &gt; 2 Pregnant woman Maximum diameter ≥ 5.1 cm Total volume lung lesion great 1/3 whole pulmonary parenchima</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>